SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases — Stella

Recruiting

Back to Tolerance trials

Trial locations(8 sites)

France

CHU d'ANGERS, Angers

CHU de Bordeaux, Bordeaux

CHRU de Brest, Brest

CHU de LILLE, Lille

CHU de Marseille, Marseille

Hôpital de la Salpétrière, Paris

CH de Quimper, Quimper

CHU de Tours, Tours

Key details

Sponsor

University Hospital, Brest

Enrollment target

~600 participants

Started

August 2021

Primary completion

February 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov